Moreover, because MFN2 T105M in this mouse model is expressed exclusively in motor neurons it has not been possible to evaluate sensory defects characteristic of clinical CMT2A. This evidence concerns the gene MFN2 and Charcot-Marie-Tooth disease type 2A1.